213 related articles for article (PubMed ID: 25089899)
1. IGF2 promotes growth of adrenocortical carcinoma cells, but its overexpression does not modify phenotypic and molecular features of adrenocortical carcinoma.
Guillaud-Bataille M; Ragazzon B; de Reyniès A; Chevalier C; Francillard I; Barreau O; Steunou V; Guillemot J; Tissier F; Rizk-Rabin M; René-Corail F; Al Ghuzlan A; Assié G; Bertagna X; Baudin E; Le Bouc Y; Bertherat J; Clauser E
PLoS One; 2014; 9(8):e103744. PubMed ID: 25089899
[TBL] [Abstract][Full Text] [Related]
2. IGF2 role in adrenocortical carcinoma biology.
Pereira SS; Monteiro MP; Costa MM; Moreira Â; Alves MG; Oliveira PF; Jarak I; Pignatelli D
Endocrine; 2019 Nov; 66(2):326-337. PubMed ID: 31378849
[TBL] [Abstract][Full Text] [Related]
3. p53 Stabilization induces cell growth inhibition and affects IGF2 pathway in response to radiotherapy in adrenocortical cancer cells.
Sampaoli C; Cerquetti L; Gawhary RE; Bucci B; Amendola D; Marchese R; Misiti S; Novelli G; Toscano V; Stigliano A
PLoS One; 2012; 7(9):e45129. PubMed ID: 23028800
[TBL] [Abstract][Full Text] [Related]
4. Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumors.
Nielsen HM; How-Kit A; Guerin C; Castinetti F; Vollan HK; De Micco C; Daunay A; Taieb D; Van Loo P; Besse C; Kristensen VN; Hansen LL; Barlier A; Sebag F; Tost J
Endocr Relat Cancer; 2015 Dec; 22(6):953-67. PubMed ID: 26400872
[TBL] [Abstract][Full Text] [Related]
5. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
6. Pediatric adrenocortical tumors: molecular events leading to insulin-like growth factor II gene overexpression.
Wilkin F; Gagné N; Paquette J; Oligny LL; Deal C
J Clin Endocrinol Metab; 2000 May; 85(5):2048-56. PubMed ID: 10843195
[TBL] [Abstract][Full Text] [Related]
7. Autocrine role of IGF-II in proliferation of human adrenocortical carcinoma NCI H295R cell line.
Logié A; Boulle N; Gaston V; Perin L; Boudou P; Le Bouc Y; Gicquel C
J Mol Endocrinol; 1999 Aug; 23(1):23-32. PubMed ID: 10425444
[TBL] [Abstract][Full Text] [Related]
8. The role of mTOR inhibitors in the inhibition of growth and cortisol secretion in human adrenocortical carcinoma cells.
De Martino MC; van Koetsveld PM; Feelders RA; Sprij-Mooij D; Waaijers M; Lamberts SW; de Herder WW; Colao A; Pivonello R; Hofland LJ
Endocr Relat Cancer; 2012 Jun; 19(3):351-64. PubMed ID: 22420007
[TBL] [Abstract][Full Text] [Related]
9. Methylation of IGF2 regulatory regions to diagnose adrenocortical carcinomas.
Creemers SG; van Koetsveld PM; van Kemenade FJ; Papathomas TG; Franssen GJ; Dogan F; Eekhoff EM; van der Valk P; de Herder WW; Janssen JA; Feelders RA; Hofland LJ
Endocr Relat Cancer; 2016 Sep; 23(9):727-37. PubMed ID: 27535174
[TBL] [Abstract][Full Text] [Related]
10. The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells.
Catalano R; Giardino E; Treppiedi D; Mangili F; Morelli V; Elli FM; Serban AL; Luconi M; Mannelli M; Spada A; Arosio M; Mantovani G; Peverelli E
Cancer Lett; 2021 Jan; 497():77-88. PubMed ID: 33075426
[TBL] [Abstract][Full Text] [Related]
11. IGF2 and IGF1R in pediatric adrenocortical tumors: roles in metastasis and steroidogenesis.
Peixoto Lira RC; Fedatto PF; Marco Antonio DS; Leal LF; Martinelli CE; de Castro M; Tucci S; Neder L; Ramalho L; Seidinger AL; Cardinalli I; Mastellaro MJ; Yunes JA; Brandalise SR; Tone LG; Rauber Antonini SR; Scrideli CA
Endocr Relat Cancer; 2016 Jun; 23(6):481-93. PubMed ID: 27185872
[TBL] [Abstract][Full Text] [Related]
12. The IGF2 methylation score for adrenocortical cancer: an ENSAT validation study.
Creemers SG; Feelders RA; Valdes N; Ronchi CL; Volante M; van Hemel BM; Luconi M; Ettaieb MHT; Mannelli M; Chiara MD; Fassnacht M; Papotti M; Kerstens MN; Nesi G; Haak HR; van Kemenade FJ; Hofland LJ
Endocr Relat Cancer; 2020 Oct; 27(10):541-550. PubMed ID: 32668404
[TBL] [Abstract][Full Text] [Related]
13. Insulin-Like Growth Factor and SLC12A7 Dysregulation: A Novel Signaling Hallmark of Non-Functional Adrenocortical Carcinoma.
Brown TC; Nicolson NG; Stenman A; Juhlin CC; Gibson CE; Callender GG; Korah R; Carling T
J Am Coll Surg; 2019 Sep; 229(3):305-315. PubMed ID: 31034883
[TBL] [Abstract][Full Text] [Related]
14. Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.
Altieri B; Sbiera S; Della Casa S; Weigand I; Wild V; Steinhauer S; Fadda G; Kocot A; Bekteshi M; Mambretti EM; Rosenwald A; Pontecorvi A; Fassnacht M; Ronchi CL
Oncotarget; 2017 Feb; 8(6):9323-9338. PubMed ID: 28030838
[TBL] [Abstract][Full Text] [Related]
15. The long non-coding RNA 91H increases aggressive phenotype of breast cancer cells and up-regulates H19/IGF2 expression through epigenetic modifications.
Vennin C; Spruyt N; Robin YM; Chassat T; Le Bourhis X; Adriaenssens E
Cancer Lett; 2017 Jan; 385():198-206. PubMed ID: 27780718
[TBL] [Abstract][Full Text] [Related]
16. Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma.
Liang R; Weigand I; Lippert J; Kircher S; Altieri B; Steinhauer S; Hantel C; Rost S; Rosenwald A; Kroiss M; Fassnacht M; Sbiera S; Ronchi CL
Front Endocrinol (Lausanne); 2020; 11():219. PubMed ID: 32373071
[TBL] [Abstract][Full Text] [Related]
17. Role of the insulin-like growth factor system in adrenocortical growth control and carcinogenesis.
Fottner Ch; Hoeflich A; Wolf E; Weber MM
Horm Metab Res; 2004 Jun; 36(6):397-405. PubMed ID: 15241731
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine kinase 1 is overexpressed and promotes adrenocortical carcinoma progression.
Xu Y; Dong B; Huang J; Kong W; Xue W; Zhu Y; Zhang J; Huang Y
Oncotarget; 2016 Jan; 7(3):3233-44. PubMed ID: 26673009
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA 91H contributes to the occurrence and progression of esophageal squamous cell carcinoma by inhibiting IGF2 expression.
Gao T; He B; Pan Y; Xu Y; Li R; Deng Q; Sun H; Wang S
Mol Carcinog; 2015 May; 54(5):359-67. PubMed ID: 24706416
[TBL] [Abstract][Full Text] [Related]
20. Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas.
Soon PS; Gill AJ; Benn DE; Clarkson A; Robinson BG; McDonald KL; Sidhu SB
Endocr Relat Cancer; 2009 Jun; 16(2):573-83. PubMed ID: 19218281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
